Sensei Biotherapeutics Net Income
| SNSE Stock | USD 9.09 0.25 2.83% |
As of the 14th of February 2026, Sensei Biotherapeutics has the Coefficient Of Variation of 4471.63, semi deviation of 5.59, and Risk Adjusted Performance of 0.0269. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sensei Biotherapeutics, as well as the relationship between them. Please validate Sensei Biotherapeutics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Sensei Biotherapeutics is priced more or less accurately, providing market reflects its prevalent price of 9.09 per share. Given that Sensei Biotherapeutics has jensen alpha of 0.0693, we advise you to double-check Sensei Biotherapeutics's current market performance to make sure the company can sustain itself at a future point.
Sensei Biotherapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Sensei Biotherapeutics' valuation are provided below:There are over one hundred nineteen available fundamental trend indicators for Sensei Biotherapeutics, which can be analyzed over time and compared to other ratios. Investors should ensure to double-check all of Sensei Biotherapeutics' current performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -27.1 M | -28.5 M | |
| Net Loss | -43.7 M | -45.9 M | |
| Net Loss | -27.1 M | -28.5 M | |
| Net Loss | (1.08) | (1.13) |
Sensei | Net Income | Build AI portfolio with Sensei Stock |
Analyzing Sensei Biotherapeutics's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Sensei Biotherapeutics's current valuation and future prospects.
Latest Sensei Biotherapeutics' Net Income Growth Pattern
Below is the plot of the Net Income of Sensei Biotherapeutics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Sensei Biotherapeutics financial statement analysis. It represents the amount of money remaining after all of Sensei Biotherapeutics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Sensei Biotherapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sensei Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (30.16 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Sensei Net Income Regression Statistics
| Arithmetic Mean | (21,158,216) | |
| Coefficient Of Variation | (52.32) | |
| Mean Deviation | 9,241,103 | |
| Median | (13,039,000) | |
| Standard Deviation | 11,070,900 | |
| Sample Variance | 122.6T | |
| Range | 35.8M | |
| R-Value | (0.74) | |
| Mean Square Error | 59T | |
| R-Squared | 0.55 | |
| Significance | 0.0007 | |
| Slope | (1,623,944) | |
| Total Sum of Squares | 1961T |
Sensei Net Income History
Other Fundumenentals of Sensei Biotherapeutics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Sensei Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Sensei Biotherapeutics is extremely important. It helps to project a fair market value of Sensei Stock properly, considering its historical fundamentals such as Net Income. Since Sensei Biotherapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sensei Biotherapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sensei Biotherapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Sensei diversify its offerings? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sensei Biotherapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Sensei Biotherapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sensei Biotherapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Sensei Biotherapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sensei Biotherapeutics' market price signifies the transaction level at which participants voluntarily complete trades.
Sensei Biotherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sensei Biotherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sensei Biotherapeutics.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Sensei Biotherapeutics on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Sensei Biotherapeutics or generate 0.0% return on investment in Sensei Biotherapeutics over 90 days. Sensei Biotherapeutics is related to or competes with Imunon, Bolt Biotherapeutics, Evogene, Cocrystal Pharma, Dogwood Therapeutics, Marker Therapeutics, and Cellectar Biosciences. Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies w... More
Sensei Biotherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sensei Biotherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sensei Biotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.83 | |||
| Information Ratio | 0.0126 | |||
| Maximum Drawdown | 36.61 | |||
| Value At Risk | (10.69) | |||
| Potential Upside | 17.33 |
Sensei Biotherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sensei Biotherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sensei Biotherapeutics' standard deviation. In reality, there are many statistical measures that can use Sensei Biotherapeutics historical prices to predict the future Sensei Biotherapeutics' volatility.| Risk Adjusted Performance | 0.0269 | |||
| Jensen Alpha | 0.0693 | |||
| Total Risk Alpha | (0.38) | |||
| Sortino Ratio | 0.0156 | |||
| Treynor Ratio | 0.1111 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sensei Biotherapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Sensei Biotherapeutics February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0269 | |||
| Market Risk Adjusted Performance | 0.1211 | |||
| Mean Deviation | 4.97 | |||
| Semi Deviation | 5.59 | |||
| Downside Deviation | 5.83 | |||
| Coefficient Of Variation | 4471.63 | |||
| Standard Deviation | 7.18 | |||
| Variance | 51.59 | |||
| Information Ratio | 0.0126 | |||
| Jensen Alpha | 0.0693 | |||
| Total Risk Alpha | (0.38) | |||
| Sortino Ratio | 0.0156 | |||
| Treynor Ratio | 0.1111 | |||
| Maximum Drawdown | 36.61 | |||
| Value At Risk | (10.69) | |||
| Potential Upside | 17.33 | |||
| Downside Variance | 33.99 | |||
| Semi Variance | 31.22 | |||
| Expected Short fall | (6.24) | |||
| Skewness | 0.9555 | |||
| Kurtosis | 2.0 |
Sensei Biotherapeutics Backtested Returns
Sensei Biotherapeutics appears to be slightly risky, given 3 months investment horizon. Sensei Biotherapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.059, which indicates the firm had a 0.059 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Sensei Biotherapeutics, which you can use to evaluate the volatility of the company. Please review Sensei Biotherapeutics' Coefficient Of Variation of 4471.63, risk adjusted performance of 0.0269, and Semi Deviation of 5.59 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Sensei Biotherapeutics holds a performance score of 4. The entity has a beta of 1.36, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sensei Biotherapeutics will likely underperform. Please check Sensei Biotherapeutics' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Sensei Biotherapeutics' existing price patterns will revert.
Auto-correlation | -0.46 |
Modest reverse predictability
Sensei Biotherapeutics has modest reverse predictability. Overlapping area represents the amount of predictability between Sensei Biotherapeutics time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sensei Biotherapeutics price movement. The serial correlation of -0.46 indicates that about 46.0% of current Sensei Biotherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.46 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 1.06 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Sensei Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Sensei Biotherapeutics reported net income of (30.16 Million). This is 108.84% lower than that of the Biotechnology sector and 143.05% lower than that of the Health Care industry. The net income for all United States stocks is 105.28% higher than that of the company.
Sensei Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sensei Biotherapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sensei Biotherapeutics could also be used in its relative valuation, which is a method of valuing Sensei Biotherapeutics by comparing valuation metrics of similar companies.Sensei Biotherapeutics is currently under evaluation in net income category among its peers.
Sensei Biotherapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sensei Biotherapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sensei Biotherapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Sensei Biotherapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Sensei Biotherapeutics that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Sensei Biotherapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sensei Biotherapeutics' value.| Shares | State Street Corp | 2025-06-30 | 0.0 | Susquehanna International Group, Llp | 2025-03-31 | 0.0 | Tower Research Capital Llc | 2025-06-30 | 0.0 | Northern Trust Corp | 2025-06-30 | 0.0 | Bridgeway Capital Management, Llc | 2025-03-31 | 0.0 | Barclays Plc | 2025-06-30 | 0.0 | Citadel Advisors Llc | 2025-03-31 | 0.0 | Xtx Topco Ltd | 2025-03-31 | 0.0 | Hrt Financial Llc | 2025-03-31 | 0.0 | Vanguard Group Inc | 2025-06-30 | 29.1 K | Ikarian Capital, Llc | 2025-06-30 | 22.5 K |
Sensei Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | (11.14 M) | ||||
| Shares Outstanding | 1.26 M | ||||
| Shares Owned By Insiders | 32.08 % | ||||
| Shares Owned By Institutions | 3.96 % | ||||
| Number Of Shares Shorted | 26.07 K | ||||
| Price To Book | 0.52 X | ||||
| EBITDA | (29.52 M) | ||||
| Net Income | (30.16 M) | ||||
| Cash And Equivalents | 123.71 M | ||||
| Cash Per Share | 4.03 X | ||||
| Total Debt | 3.85 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 23.46 X | ||||
| Book Value Per Share | 18.24 X | ||||
| Cash Flow From Operations | (24.67 M) | ||||
| Short Ratio | 0.25 X | ||||
| Earnings Per Share | (19.14) X | ||||
| Target Price | 32.5 | ||||
| Number Of Employees | 14 | ||||
| Beta | 0.28 | ||||
| Market Capitalization | 11.47 M | ||||
| Total Asset | 45.36 M | ||||
| Retained Earnings | (262.05 M) | ||||
| Working Capital | 36.48 M | ||||
| Net Asset | 45.36 M |
About Sensei Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sensei Biotherapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sensei Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sensei Biotherapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sensei Biotherapeutics is a strong investment it is important to analyze Sensei Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sensei Biotherapeutics' future performance. For an informed investment choice regarding Sensei Stock, refer to the following important reports:Check out For information on how to trade Sensei Stock refer to our How to Trade Sensei Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Biotechnology sector continue expanding? Could Sensei diversify its offerings? Factors like these will boost the valuation of Sensei Biotherapeutics. If investors know Sensei will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sensei Biotherapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Sensei Biotherapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sensei Biotherapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Sensei Biotherapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sensei Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sensei Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sensei Biotherapeutics' market price signifies the transaction level at which participants voluntarily complete trades.